FDA to Review Experimental ALS Treatment This Week

Published on September 25, 2023

The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease. Those advocates still face one giant hurdle: FDA…

Read Full Article (External Site)